Barclays’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000	Closed	-$60K	–	6217
2019 Q4	$60K	Sell	1,000 -1,900	-66%	-$85.4K	﹤0.01%	5684
2019 Q3	$106K	Hold	2,900	–	–	﹤0.01%	5436
2019 Q2	$135K	Buy	2,900 +1,800	+164%	+$84.5K	﹤0.01%	5450
2019 Q1	$44K	Sell	1,100 -400	-27%	-$17.9K	﹤0.01%	5965
2018 Q4	$69K	Sell	1,500 -24,200	-94%	-$1.17M	﹤0.01%	5281
2018 Q3	$1.14M	Buy	25,700 +1,800	+8%	+$82.6K	﹤0.01%	3501
2018 Q2	$937K	Buy	23,900 +23,500	+5,875%	+$1.19M	﹤0.01%	3358
2018 Q1	$29K	Buy	400 +300	+300%	+$22K	﹤0.01%	6262
2017 Q4	$7K	Hold	100	–	–	﹤0.01%	6595
2017 Q3	$5K	Sell	100 -74,900	-100%	-$3.61M	﹤0.01%	6404
2017 Q2	$3.47M	Buy	+75,000	New	+$2.76M	﹤0.01%	1759
2015 Q3	–	Sell	-2,500	Closed	-$203K	–	6884
2015 Q2	$203K	Buy	+2,500	New	+$245K	﹤0.01%	4133